Your browser is no longer supported. Please, upgrade your browser.
Settings
ANVS [AMEX]
Annovis Bio, Inc.
Index- P/E- EPS (ttm)-1.20 Insider Own0.10% Shs Outstand7.37M Perf Week-9.74%
Market Cap233.98M Forward P/E- EPS next Y-2.57 Insider Trans7.08% Shs Float5.64M Perf Month-11.82%
Income-8.40M PEG- EPS next Q-0.38 Inst Own19.90% Short Float6.70% Perf Quarter-67.79%
Sales- P/S- EPS this Y-498.10% Inst Trans40.68% Short Ratio0.55 Perf Half Y-12.82%
Book/sh6.60 P/B4.69 EPS next Y-60.60% ROA-46.20% Target Price- Perf Year480.68%
Cash/sh6.51 P/C4.76 EPS next 5Y- ROE-48.40% 52W Range4.14 - 132.00 Perf YTD310.48%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-76.55% Beta-
Dividend %- Quick Ratio56.00 Sales past 5Y- Gross Margin- 52W Low647.58% ATR2.89
Employees2 Current Ratio56.00 Sales Q/Q- Oper. Margin- RSI (14)34.35 Volatility9.94% 7.86%
OptionableNo Debt/Eq0.00 EPS Q/Q-1.80% Profit Margin- Rel Volume0.32 Prev Close33.50
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume686.77K Price30.95
Recom2.00 SMA20-13.22% SMA50-46.19% SMA200-19.87% Volume220,760 Change-7.61%
Jul-07-21Reiterated Maxim Group Buy $45 → $150
Sep-20-21 10:47PM  
06:35PM  
02:47PM  
01:45PM  
12:15PM  
11:15AM  
11:00AM  
10:15AM  
09:20AM  
08:25AM  
05:50AM  
Sep-19-21 10:33PM  
09:09PM  
12:26PM  
Sep-18-21 03:43PM  
Sep-17-21 10:00PM  
04:09PM  
03:57PM  
02:35PM  
12:20PM  
12:00PM  
11:40AM  
11:00AM  
09:15AM  
08:45AM  
06:00AM  
Sep-16-21 11:00PM  
07:30PM  
11:35AM  
11:30AM  
10:15AM  
08:40AM  
Sep-15-21 10:50PM  
08:58PM  
07:30PM  
07:28PM  
07:15PM  
03:50PM  
10:54AM  
10:21AM  
09:00AM  
05:20AM  
Sep-14-21 10:50PM  
04:00PM  
12:45PM  
12:15PM  
12:08PM  
12:00PM  
12:00PM  
12:00PM  
11:00AM  
11:00AM  
10:21AM  
10:00AM  
05:40AM  
Sep-13-21 10:50PM  
09:14PM  
07:15PM  
06:30PM  
06:00PM  
04:31PM  
04:10PM  
12:30PM  
11:35AM  
11:30AM  
11:10AM  
11:00AM  
10:30AM  
10:18AM  
10:00AM  
09:05AM  
05:40AM  
Sep-12-21 11:30AM  
10:30AM  
10:01AM  
Sep-10-21 10:50PM  
08:02PM  
06:27PM  
04:57PM  
01:45PM  
11:00AM  
10:30AM  
10:00AM  
09:24AM  
09:15AM  
09:00AM  
08:30AM  
05:40AM  
Sep-09-21 09:45PM  
08:08PM  
02:15PM  
02:15PM  
01:00PM  
01:00PM  
12:05PM  
11:35AM  
11:05AM  
11:00AM  
10:15AM  
10:05AM  
Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is ANVS401, which is in Phase 2a clinical trials for the treatment of Alzheimer's disease (AD), Parkinson's disease, Alzheimer's disease in Down Syndrome, and other chronic neurodegenerative disorders. It is also developing ANVS405 for protecting the brain after traumatic brain injury and/or stroke; and ANVS301, which is in Phase I clinical trials to increase cognitive capability in later stages of AD and dementia. The company was incorporated in 2008 and is based in Berwyn, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
McCarthy ReidDirectorAug 19Buy37.6150018,8056,829Aug 23 11:36 AM